IPP Bureau
India’s Drugs Controller General green lights trial of TRIA heart valve
By IPP Bureau - May 04, 2022
The procedures have been performed by Dr. Kaushal Pandey at P.D. Hinduja Hospital in Mumbai, India
Aleor Dermaceuticals receives USFDA approval for Docosanol Cream
By IPP Bureau - May 04, 2022
Docosanol Cream, 10% (OTC) has an estimated market size of US$60 million for twelve months ending December 2021 according to IQVIA
Kokilaben Dhirubhai Ambani Hospital launches third da Vinci robotic surgical system
By IPP Bureau - May 04, 2022
It is the first hospital in the country to achieve the significant milestone of completing over 2600 robotic surgeries for treating patients with prostate, kidney and urinary bladder cancer
Gland launches Bortezomib in the US market
By IPP Bureau - May 04, 2022
Bortezomib for injection is used to treat certain types of cancer such as multiple myeloma and mantle cell lymphoma
Foundation S: Sanofi’s new philanthropic spearhead
By IPP Bureau - May 04, 2022
Foundation S will incorporate as its cornerstone initiative the former Sanofi Espoir Foundation’s ‘My Child Matters’ program in childhood cancer
Mylab launches RT-PCR test for Ankylosing Spondylitis ahead of the World AS Day
By IPP Bureau - May 04, 2022
This RT-PCR diagnostic kit helps in diagnosis of AS by detecting HLAB27 gene
GOQii launches first of its kind one-stop solution for Diabetes care in India
By IPP Bureau - May 04, 2022
An Integrated programme comprising GOQii device, Glucometer – Contour Plus+1 from Ascensia Diabetes Care India and personalised diabetes coaching
Pfizer sets up global drug development centre in Chennai
By IPP Bureau - May 04, 2022
The facility is among 12 centres established worldwide, and the first in Asia
Sona Group partners with Mycelium Biotechnology for R&D in Salem
By IPP Bureau - May 02, 2022
As a global mushroom biotechnology group, Mycelium Biotechnology is engaged in mushroom growing, global distribution and offering biotechnology and nutraceutical solutions through global partners
Xcardia announces first-in-human use of its new Xtractor device
By IPP Bureau - May 02, 2022
The announcement follows FDA 510(k) clearance of device
NORD announces over US $ 100,000 in grant funding available for rare disease research
By IPP Bureau - May 02, 2022
Three RFPs now open for qualified researchers through NORD's Jayne Holtzer rare disease research grants program
CIVCO Radiotherapy to Unveil TotalRT All in One Solution at ESTRO 2022
By IPP Bureau - May 02, 2022
CIVCO RT will also display its recent innovations focusing on improving patient comfort and outcomes
World’s first AI software for detecting pancreatic disease on the horizon
By IPP Bureau - May 02, 2022
As an industrial partner of the IHU, the Medi-Globe Group is thus further expanding its role as an innovation leader in minimally invasive diagnostics and therapies
Intravacc signs an exclusive license agreement with Zhifei Lvzhu Biopharmaceutical
By IPP Bureau - May 02, 2022
Avacc 3 has significant advantages over existing whooping cough vaccines
StanPlus appoints Gurjit Singh as COO and Founding Member
By IPP Bureau - May 02, 2022
He will be leading the business, operations, P&L, and growth strategy for StanPlus
